Search

Search Constraints

You searched for: Author/Creator Asahina, Yasuhiro

Search Results

1. Association of serum interferon‐λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct‐acting antiviral agents. Issue 5 (7th February 2019)

2. Bone morphogenetic protein‐4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Issue 9 (31st October 2016)

3. Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma. Issue 2 (7th October 2013)

4. Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma. Issue 2 (7th October 2013)

5. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy. Issue 4 (24th January 2023)

6. Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma. Issue 4 (15th September 2015)

7. Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors. Issue 5 (27th January 2023)

8. Guidelines for the Management of Hepatitis C Virus Infection. Issue 1 (18th January 2013)

9. Hepatic IFNL4 expression is associated with non‐response to interferon‐based therapy through the regulation of basal interferon‐stimulated gene expression in chronic hepatitis C patients. Issue 7 (27th February 2017)

10. Hepatitis C virus NS4B protein targets STING and abrogates RIG‐I–mediated type I interferon‐dependent innate immunity123. Issue 1 (7th January 2013)